首站-论文投稿智能助手
典型文献
Deciphering tau-related dementia using human iPSC lines:electrophysiological perspectives of future studies
文献摘要:
To date,no disease-modifying treatment or cure is available for dementia.This disorder is becoming more common as the global population ages.There has been over several decades of extensive research focusing on how the pathology develops and progresses causing memory loss,brain damage,and eventually death-it provides the field with a deep understanding of what proteins,peptides,and signaling molecules contribute to neurodegeneration at the molecular,genetic,and cellular levels.
文献关键词:
作者姓名:
Olga Kopach
作者机构:
Queen Square Institute of Neurology,University College London,London,UK
引用格式:
[1]Olga Kopach-.Deciphering tau-related dementia using human iPSC lines:electrophysiological perspectives of future studies)[J].中国神经再生研究(英文版),2022(12):2672-2674
A类:
B类:
Deciphering,tau,related,dementia,human,iPSC,lines,electrophysiological,perspectives,future,studies,To,date,no,disease,modifying,treatment,cure,available,This,disorder,becoming,more,common,global,population,ages,There,has,been,over,several,decades,extensive,research,focusing,how,pathology,develops,progresses,causing,memory,loss,brain,damage,eventually,death,provides,field,deep,understanding,what,proteins,peptides,signaling,molecules,contribute,neurodegeneration,molecular,genetic,cellular,levels
AB值:
0.822635
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
Dementia in military and veteran populations: a review of risk factors—traumatic brain injury, post?traumatic stress disorder, deployment, and sleep
Zara Raza;Syeda F.Hussain;Suzanne Ftouni;Gershon Spitz;Nick Caplin;Russell G.Foster;Renata S.M.Gomes-Research and Innovation,Blind Veterans UK,12?14 Harcourt Street,London W1H 4HD,UK;BRAVO VICTOR,Research,12?14 Harcourt Street,London W1H 4HD,UK;Circadian Therapeutics,Oxford OX11BY,UK;School of Psychological Sciences,Monash University,18 Innovation Walk,Clayton Campus,Wellington Road,Melbourne,VIC 3800,Australia;Sleep&Circadian Neuroscience Institute (SCNi),Nuffield Department of Clinical Neurosciences,Sir William Dunn School of Pathology,Oxford Molecular Pathology Institute,University of Oxford,South Parks Road,Oxford OX13RF,UK;Northern Hub for Veterans and Military Families Research,Department of Nursing,Midwifery and Health,Faculty of Health and Life Sciences,Northumbria University,Newcastle NE77XA,UK
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。